Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes.

Kirkham, Kylian; Munson, Jessica M; McCluskey, Susan V; Graner, Kevin K

Kirkham, Kylian; Munson, Jessica M; McCluskey, Susan V; Graner, Kevin K.

Affiliation

Kirkham K; Mayo Clinic Rochester, Rochester, Minnesota. kirkham.kylian@mayo.edu.
Munson JM; ARL Biopharma, Inc., Oklahoma City, Oklahoma.
McCluskey SV; Mayo Clinic Rochester, Rochester, Minnesota.
Graner KK; Mayo Clinic Rochester, Rochester, Minnesota.

Int J Pharm Compd ; 21(5): 426-429, 2017.

Article in En | MEDLINE | ID: mdl-29216619

Subject(s)

Dalteparin/chemistry; Chromatography, High Pressure Liquid; Dalteparin/analysis; Dalteparin/pharmacology; Drug Stability; Factor Xa Inhibitors/pharmacology; Hydrogen-Ion Concentration; Injections; Polypropylenes; Sodium Chloride; Syringes

Search on Google

XML

PubMed Links